Prolonged oral corticosteroid treatment in patients with systemic lupus erythematosus: An evaluation of 12-month economic and clinical burden

BACKGROUND: Prolonged, high-dose corticosteroid treatment for systemic lupus erythematosus (SLE) is associated with substantial health care costs, health care resource utilization (HCRU), and adverse events (AEs). OBJECTIVE: To compare all-cause health care costs, HCRU, and oral corticosteroid (OCS)...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Shirley P, DerSarkissian, Maral, Gu, Yuqian M, Duh, Mei Sheng, Wang, Min-Jung, Benson, John, Vu, Jensen, Averell, Carlyne, Bell, Christopher F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387938/
https://www.ncbi.nlm.nih.gov/pubmed/36989451
http://dx.doi.org/10.18553/jmcp.2023.29.4.365

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387938/
https://www.ncbi.nlm.nih.gov/pubmed/36989451
http://dx.doi.org/10.18553/jmcp.2023.29.4.365

Ejemplares similares